409A valuation AI Medical Service AOT asset valuation Biotech firms Biotechgate Biotechgate Digital Partnering brain activity measuring breast cancer Cells clinical trial database Cold Ablation Robotguided Laser Osteotome cranio-maxillofacial surgery Cyrill Bätscher early digestive track cancer detection Ferring Pharmaceutical filming Fujieda Ayumi Funding future of life sciences Gergely Ivanyi German Biotech German Life Sciences GTAI Health Made in Germany Heartseed Inc. HelloPartnering in-licensing opportunities JPM San Francisco Kiyoshi Hasegawa life science database Lily MedTech Inc. medical image analysis NeU Corporation patrik frei product valuation RESI Rhine-Main-Neckar biotech SARS CoV 2 Shiho Azuma Tomohiro Tada valuation Valuation Experts XB-01 Yone Production Co Ltd
Developing a promising therapeutic technology which may contribute to treat various amyloidosis related diseases, incl. Alzheimer’s Disease.
Venture Valuation (VV) interviewed TORII Shin-ichi, Ph.D., founder and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
Established by KOBAYASHI Yonesaku, a well-known documentary cameraman and pioneer of cinephotomicrography, and Dr ASAKA Tokio, anatomist and expert in biological sample research and development, Yone Production has played a vital role over 50 years in supporting scientific advancement and promoting scientific films.
Venture Valuation (VV) interviewed FUJIEDA Ayumi, CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
April 2021: Started in Basel by three experienced Partners, Forty51 Ventures targets seed and early-stage investments in underfunded Biotech clusters in Switzerland, Germany, Eastern France, Northern Italy, and Austria.
Venture Valuation (VV) interviewed Sascha Oliver Bucher, Co-Founder and Partner.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
September 2020: Expert in big data analysis primarily in the legal tech business using its NLP AI technology, FRONTEO is applying its knowhow in the fields of life sciences and health care.
Venture Valuation (VV) interviewed TOYOSHIBA Hiroyoshi PhD, CTO Life Science AI Business Division, and YAMAMOTO Mari, Member of the Board of Directors.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
May 2020: Founded by a woman engineer caring for women’s health, the 3D whole breast ultrasound diagnostic imaging system demonstrates not only leading-edge technology but also considerate features for examinees.
Venture Valuation (VV) interviewed, Mrs. Shiho AZUMA, Founder and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
As an industry-university joint venture of Hitachi High Technology Division and Tohoku University Institute of Development, Aging and Cancer, NeU is introducing a unique brain activity measuring device for individual use.
Venture Valuation (VV) interviewed Kiyoshi Hasegawa, CEO of NeU.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
Founded by an accomplished gastroenterologist, AI Medical Service is determined to contribute to the detection of early cancer in the digestive tract by leveraging a CNN deep learning algorithm.
Venture Valuation (VV) interviewed Tomohiro Tada, Founder and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
Founded by four experts in laser physics, medical image analysis, and cranio-maxillofacial surgery, AOT is reinventing the bone surgery field with laser osteotomy technology: CARLO® (Cold Ablation Robotguided Laser Osteotome).
Applying intelligently glycemic control and a systematic route through the BBB (blood-brain barrier) to effectively reach neurons. Venture Valuation (VV) interviewed the CEO, Mariko Tosu, PhD (more…)
ITO has developed, since its inception in 1916, high-end professional use therapeutic modalities as well as innovative personal use devices.
Venture Valuation (VV) interviewed the COO, Mayuko Ito, great-granddaughter of the founder Kenji Ito.